Though largely absent from mainstream news, proposed reforms to patent law are poised to affect everything from biotech startups to major pharmaceutical R&D programs. Specifically, there are four ongoing bipartisan efforts to...more
8/27/2025
/ Biosimilars ,
Biotechnology ,
Emerging Growth Companies ,
Injunctions ,
Intellectual Property Protection ,
Life Sciences ,
Patent Infringement ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Patent-Eligible Subject Matter ,
Pharmaceutical Patents ,
Proposed Legislation ,
R&D ,
Regulatory Agenda ,
Research and Development ,
Scientific Research ,
Startups ,
USPTO